Related Experiment Video
Updated: Jan 8, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Enhancing type 2 diabetes care by an individualized and group-based therapeutic patient education program: study
David Ehlig1, Maxime Sapin2, Minette-Joëlle Zeukeng3
1Chair of Health Economics, Policy and Management, School of Medicine, University of St. Gallen, St. Gallen, Switzerland. david.ehlig@unisg.ch.
This study investigates if an individualized, interdisciplinary program improves type 2 diabetes (T2D) outcomes. The intervention includes therapeutic patient education (TPE) to enhance patient health.
Area of Science:
- Endocrinology
- Public Health
- Healthcare Management
Background:
- Type 2 diabetes (T2D) prevalence is rising globally, necessitating effective management strategies.
- Lifestyle factors like diet and exercise significantly impact T2D, highlighting the importance of patient education.
- Current T2D care in Switzerland infrequently incorporates therapeutic patient education (TPE) within standard protocols.
Purpose of the Study:
- To evaluate the effectiveness of an interdisciplinary, individualized T2D program incorporating TPE elements.
- To assess if the TPE-enhanced program improves health outcomes for recently diagnosed T2D patients.
Main Methods:
- A multi-center cluster randomized controlled trial involving 154 T2D patients across 30 primary care physician practices in Geneva, Switzerland.
- Intervention group: PCPs and healthcare professionals trained in TPE; patients receive individualized treatment plans and regular PROMs. Control group: standard care.
- 12-month intervention with 6-month follow-up; primary endpoint: change in HbA1c; secondary endpoints: PROMs, medical outcomes, patient experience, and cost-effectiveness.
Main Results:
- Primary endpoint: 12-month mean change in HbA1c levels.
- Secondary endpoints: 18-month HbA1c changes, patient-reported outcomes (EQ-5D-5L, DIAB-Q), medical outcomes (blood pressure, body composition, medication), and patient experience.
- Cost-effectiveness analysis from the payer perspective will be conducted.
Conclusions:
- Positive study findings could support broader implementation of T2D programs in Switzerland.
- The program aims to be a cornerstone for improving T2D patient health outcomes.
- The study is registered on ClinicalTrials.gov (NCT06774950).
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

